Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ACET

Adicet Bio Inc

Dec 08 • 04:00PM ET

1.38

Dollar change +0.01
Percentage change 0.73	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.35	Insider Own	29.67%	Shs Outstand	42.95M	Perf Week	12.20%
Market Cap	59.56M	Forward P/E	-	EPS next Y	-2.50	Insider Trans	15.88%	Shs Float	30.36M	Perf Month	3.76%
Income	-143.04M	PEG	-	EPS next Q	-0.67	Inst Own	56.47%	Short Float / Ratio	9.98% / 8.12	Perf Quarter	-18.82%
Sales	0.00M	P/S	-	EPS this Y	-93.03%	Inst Trans	10.33%	Short Interest	3.03M	Perf Half Y	-74.21%
Book/sh	4.52	P/B	0.31	EPS next Y	23.90%	ROA	-48.69%	Target Price	15.67	Perf Year	-92.97%
Cash/sh	4.25	P/C	0.33	EPS next 5Y	29.10%	ROE	-55.84%	52W Range	1.10 - 19.98	Perf YTD	-84.56%
Dividend	-	P/FCF	-	EPS past 5Y	50.81%	ROI	-67.05%	52W High	-93.09%	Beta	1.78
Dividend %	-	Quick Ratio	9.40	Sales past 5Y	362.10%	Gross Margin	79.96%	52W Low	25.45%	ATR	0.11
Employees	132	Current Ratio	9.40	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	59.30	Volatility	10.34% 8.19%
Optionable	Yes	Debt/Eq	0.11	EPS Q/Q	-119.73%	Profit Margin	-	Rel Volume	0.81	Prev Close	1.37
Shortable	Yes	LT Debt/Eq	0.10	Earnings	Nov 08 AMC	Payout	-	Avg Volume	373.44K	Price	1.38
Recom	1.80	SMA20	14.95%	SMA50	5.93%	SMA200	-62.39%	Volume	302,863	Change	0.73%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-27-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-27-23	Downgrade	Guggenheim	Buy → Neutral
Jun-01-23	Downgrade	JP Morgan	Overweight → Neutral	$20 → $6
Sep-21-22	Initiated	JP Morgan	Overweight	$23
Mar-31-22	Initiated	SMBC Nikko	Outperform	$28
Mar-08-22	Initiated	Truist	Buy	$30
Mar-04-22	Initiated	Jefferies	Buy	$27
May-18-21	Initiated	BTIG Research	Buy	$34
Apr-23-21	Initiated	H.C. Wainwright	Buy	$27
Apr-14-21	Initiated	Canaccord Genuity	Buy	$28
Apr-08-21	Initiated	Guggenheim	Buy	$22
Nov-04-20	Initiated	B. Riley Securities	Buy	$30
Oct-27-20	Initiated	JMP Securities	Mkt Outperform	$30
Oct-16-20	Initiated	Wedbush	Outperform	$25

Show Previous Ratings

Nov-08-23 04:10PM	Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates (Business Wire)
Nov-07-23 07:00AM	Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference (Business Wire) -8.04%
Nov-02-23 09:00AM	Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting (Business Wire) +13.85%
Oct-31-23 06:25PM	Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-04-23 12:00PM	Adicet Bio Announces Poster Presentation at the Upcoming 2023 Molecular Targets and Cancer Therapeutics Conference (Business Wire)
05:24PM	Loading…
Sep-29-23 05:24PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-27-23 09:00AM	Adicet Bio to Present Three Scientific Posters Highlighting its Allogeneic Gamma Delta T Cell Platform and Programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting (Business Wire)
Aug-31-23 04:35PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +11.11%
Aug-12-23 08:16AM	Will Adicet Bio (NASDAQ:ACET) Spend Its Cash Wisely? (Simply Wall St.)
Aug-09-23 04:15PM	Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates (Business Wire)
Aug-02-23 04:00PM	Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference (Business Wire)
Jul-31-23 04:50PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-11-23 08:30AM	Adicet Announces Appointment of Katie Peng to the Board of Directors (Business Wire)
Jun-30-23 04:51PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.19%
Jun-26-23 04:00PM	Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire)
07:00AM	Loading…
Jun-01-23 07:00AM	Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference (Business Wire) -5.20%
May-31-23 04:53PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-18-23 06:00AM	Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting (Business Wire)
May-09-23 04:30PM	Adicet Bio to Present at the 2023 JMP Securities Life Sciences Conference (Business Wire)
04:10PM	Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates (Business Wire)
Apr-28-23 05:13PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-26-23 08:01PM	7 Biotech Stocks With Huge Return Potential for Long-Term Investors (InvestorPlace)
Apr-17-23 06:58AM	Adicet Bio, Inc.'s (NASDAQ:ACET) Price Is Out Of Tune With Revenues (Simply Wall St.) +9.45%
Apr-13-23 07:00AM	Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire) +9.68%
Apr-04-23 02:47PM	Down More Than 60%: Analysts Say Buy These 3 Beaten-Down Stocks Before They Rebound (TipRanks) -6.14%
Mar-31-23 04:31PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-15-23 04:01PM	Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress (Business Wire)
11:44AM	7 Biotech Stocks That Could Be the Next Big Thing (InvestorPlace)
Mar-09-23 07:00AM	Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit (Business Wire)
Mar-05-23 07:09AM	Adicet Bio (NASDAQ:ACET) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
05:31PM	Loading…
Feb-28-23 05:31PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-01-23 07:00AM	Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference (Business Wire)
Jan-31-23 08:40PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.29%
Dec-30-22 04:43PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-20-22 08:23AM	Shareholders in Adicet Bio (NASDAQ:ACET) have lost 49%, as stock drops 22% this past week (Simply Wall St.)
Dec-10-22 10:00AM	Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire)
Dec-02-22 07:00AM	Adicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire)
Nov-30-22 08:08PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
04:00PM	Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit (Business Wire)
Nov-29-22 07:00AM	Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer (Business Wire) +6.41%
Nov-11-22 05:24AM	Adicet Bio Third Quarter 2022 Earnings: US$0.53 loss per share (vs US$0.44 loss in 3Q 2021) (Simply Wall St.)
Nov-08-22 04:10PM	Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
Nov-07-22 08:00AM	Adicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (Business Wire) +7.22%
Nov-03-22 09:00AM	Adicet Bio Reports ASH Abstract Data from Ongoing ADI-001 Phase 1 Trial in Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire) +5.16%
Nov-01-22 07:00AM	Adicet Bio to Present at the 2022 Jefferies London Healthcare Conference (Business Wire)
Oct-31-22 06:58PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-23-22 08:39AM	Calculating The Intrinsic Value Of Adicet Bio, Inc. (NASDAQ:ACET) (Simply Wall St.)
Oct-05-22 08:00AM	Adicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (Business Wire)
Sep-30-22 06:59PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.88%
Sep-26-22 06:26AM	We're Hopeful That Adicet Bio (NASDAQ:ACET) Will Use Its Cash Wisely (Simply Wall St.)
Sep-07-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire)
Aug-31-22 05:30PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-16-22 06:16AM	The Consensus EPS Estimates For Adicet Bio, Inc. (NASDAQ:ACET) Just Fell Dramatically (Simply Wall St.) -8.67%
Aug-10-22 07:00AM	Adicet Reports Second Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
Aug-01-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire)
Jul-29-22 06:05PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-01-22 04:10PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-21-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire)
Jun-06-22 07:00AM	Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting (Business Wire) +6.61%
Jun-03-22 04:10PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-26-22 05:00PM	Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkins Lymphoma (NHL) (Business Wire)
May-18-22 04:00PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire) -12.42%
May-15-22 08:21AM	Results: Adicet Bio, Inc. Confounded Analyst Expectations With A Surprise Profit (Simply Wall St.)
May-12-22 04:10PM	Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
11:14AM	Further weakness as Adicet Bio (NASDAQ:ACET) drops 31% this week, taking one-year losses to 17% (Simply Wall St.)
May-05-22 07:00AM	Adicet Presents Preclinical Data at the ISCT Annual Meeting Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies (Business Wire)
May-04-22 04:10PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-27-22 10:00AM	Adicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (Business Wire) +6.78%
Apr-19-22 07:00AM	Adicet Bio Receives FDA Fast Track Designation for Lead Candidate ADI-001 (Business Wire)
Apr-07-22 04:10PM	Adicet Bio to Participate in Upcoming Investor Conferences (Business Wire)
Apr-01-22 04:10PM	Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-22-22 12:47PM	The Biotech Sector Nears an Inflection Point; Analysts Offer 3 Stocks to Consider (TipRanks) +10.85%
Mar-15-22 04:00PM	Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress (Business Wire) +5.53%
07:25AM	Here's Why We're Not Too Worried About Adicet Bio's (NASDAQ:ACET) Cash Burn Situation (Simply Wall St.)
Mar-04-22 04:00PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-02-22 07:00AM	Adicet Bio to Participate in Guggenheim 2022 Oncology Conference (Business Wire)
Dec-10-21 04:01PM	Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Dec-09-21 05:49PM	How a biotech is turning 'road bikes' into 'mountain bikes' to roll over cancer (American City Business Journals) -10.14%
Dec-08-21 01:13AM	Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire) +5.52%
Dec-07-21 04:16PM	Adicet Bio, Inc. Announces Proposed Follow-On Offering of Common Stock (GlobeNewswire) +6.78%
Dec-06-21 07:00AM	Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy (GlobeNewswire) +38.47%
Nov-29-21 07:00AM	Adicet Bio to Host Webcast Presentation of ADI-001 Interim Clinical Data in B Cell Non-Hodgkins Lymphoma (GlobeNewswire)
Nov-20-21 06:00AM	Adicet Bio (NASDAQ:ACET) shareholders have endured a 27% loss from investing in the stock a year ago (Simply Wall St.)
Nov-18-21 07:00AM	Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors (GlobeNewswire)
Nov-12-21 07:00AM	Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting (GlobeNewswire)
Nov-10-21 04:01PM	Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-08-21 07:00AM	Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference (GlobeNewswire)
Nov-04-21 09:00AM	Adicet Announces Trials in Progress Poster Presentation for ADI-001 at 2021 ASH Annual Meeting (GlobeNewswire)
Oct-26-21 03:00AM	CDR-Life Announces Expansion of Scientific Advisory Board (GlobeNewswire)
Oct-12-21 04:10PM	Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer (GlobeNewswire)
Oct-04-21 07:00AM	Adicet to Present Preclinical Data from Allogeneic Gamma Delta T Cell Platform at SITC 36th Annual Meeting (GlobeNewswire)
Sep-13-21 08:00AM	Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics (Business Wire)
08:00AM	Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics (GlobeNewswire)
Sep-02-21 04:53PM	Adicet Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-12-21 04:01PM	Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-02-21 07:00AM	Adicet Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-30-21 10:35AM	Is Adicet Bio Inc. (ACET) A Good Stock To Buy? (Insider Monkey)
Jul-15-21 07:00AM	Adicet Bio Announces Formation of Scientific Advisory Board (GlobeNewswire)
Jun-28-21 07:00AM	Adicet Bio Added to the Russell 2000® Index (GlobeNewswire)
May-18-21 04:10PM	Adicet Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of "off-the-shelf" gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schor Chen	President & CEO	Oct 02	Buy	1.33	5,500	7,340	43,469	Oct 02 08:16 PM
Schor Chen	President & CEO	Sep 29	Sale	1.36	5,500	7,481	176,969	Oct 02 08:16 PM
Schor Chen	President & CEO	Sep 28	Buy	1.42	5,500	7,810	182,469	Oct 02 08:16 PM
Schor Chen	President & CEO	Sep 28	Sale	1.42	5,500	7,810	37,969	Oct 02 08:16 PM
DUBIN STEVE	Director	Jun 30	Buy	2.40	5,000	12,000	10,900	Jun 30 04:08 PM
GORDON CARL L	Director	Jun 27	Buy	2.09	875,000	1,828,750	5,685,259	Jun 29 04:51 PM
ORBIMED ADVISORS LLC	Director	Jun 27	Buy	2.09	875,000	1,828,750	5,685,259	Jun 29 04:46 PM
Healey Don	Chief Technology Officer	Feb 15	Sale	7.57	4,533	34,327	66,568	Feb 17 08:22 PM
Healey Don	Chief Technology Officer	Feb 10	Sale	7.98	10,467	83,476	71,101	Feb 14 04:50 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACET

Adicet Bio Inc

Upgrade your FINVIZ experience